Westchester Capital Management (New York)’s Frazier Lifesciences Acquisition Corporation Class A Ordinary Shares FLAC Stock Holding History

Westchester Capital Management (New York)’s Portfolio FLAC Stock Details FLAC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-73,677	Closed	-$734K	–	581
2022 Q3	$734K	Buy	+73,677	New	+$731K	0.02%	363

Westchester Capital Management (New York)'s FLAC Position: Q4 2022 in Review

Westchester Capital Management (New York) sold out of Frazier Lifesciences Acquisition Corporation Class A Ordinary Shares (FLAC) in Q4 2022, closing a stake of 73,677 shares — an estimated $734K sold.

Westchester Capital Management (New York) first reported a position in FLAC in Q3 2022 and held it in 1 quarter. The position peaked at $734K in Q3 2022. 0 funds tracked by Wall St. Rank hold FLAC as of Q4 2022.

Westchester Capital Management (New York) reported no remaining Frazier Lifesciences Acquisition Corporation Class A Ordinary Shares position as of Q4 2022 after selling out during the quarter.
Westchester Capital Management (New York) sold 73,677 Frazier Lifesciences Acquisition Corporation Class A Ordinary Shares shares in Q4 2022, an estimated $734K.
Westchester Capital Management (New York) first reported a position in Frazier Lifesciences Acquisition Corporation Class A Ordinary Shares in Q3 2022 and held it in 1 quarter.
Westchester Capital Management (New York)'s Frazier Lifesciences Acquisition Corporation Class A Ordinary Shares position peaked at $734K in Q3 2022.
0 funds tracked by Wall St. Rank held Frazier Lifesciences Acquisition Corporation Class A Ordinary Shares as of Q4 2022.

Based on Westchester Capital Management (New York)'s 13F filing for Q4 2022, filed 14 Feb 2023.